Associate Professor John Ashton

Marchalant, Y., Brownjohn, P. W., Bonnet, A., Kleffmann, T., & Ashton, J. C. (2014). Validating antibodies to the cannabinoid CB2 receptor: Antibody sensitivity is not evidence of antibody specificity. Journal of Histochemistry & Cytochemistry, 62(6), 395-404. doi: 10.1369/0022155414530995 Journal - Research Article

Brownjohn, P. W., & Ashton, J. C. (2014). What can be concluded from blocking peptide controls? Applied Immunohistochemistry & Molecular Morphology, 22(8), 634. doi: 10.1097/PAI.0b013e3182a77fe5 Journal - Research Other

Ashton, J. C. (2013). Experimental power comes from powerful theories: The real problem in null hypothesis testing. Nature Reviews Neuroscience, 14, 585. doi: 10.1038/nrn3475-c2 Journal - Research Other

Rivers, J. R., & Ashton, J. C. (2013). Neonatal asphyxia and stroke: Morbidity, models, consequences, and treatments. In D. Vordermark (Ed.), Hypoxia: Causes, types and management. (pp. 89-110). New York: Nova. Chapter in Book - Research

Rivers, J. R., & Ashton, J. C. (2013). Age matching animal models to humans: Theoretical considerations. Current Drug Discovery Technologies, 10(3), 177-181. Journal - Research Article

Baek, J.-H., Darlington, C. L., Smith, P. F., & Ashton, J. C. (2013). Antibody testing for brain immunohistochemistry: Brain immunolabeling for the cannabinoid CB₂ receptor. Journal of Neuroscience Methods, 216(2), 87-95. doi: 10.1016/j.jneumeth.2013.03.021 Journal - Research Article

Rivers-Auty, J., & Ashton, J. C. (2013). Vehicles for lipophilic drugs: Implications for experimental design, neuroprotection, and drug discovery. Current Neurovascular Research, 10(4), 356-360. doi: 10.2174/15672026113109990021 Journal - Research Other

Ashton, J. C. (2013). Phylogenetic methods in drug discovery. Current Drug Discovery Technologies, 10(4), 255-262. doi: 10.2174/15701638113109990033 Journal - Research Article

Brownjohn, P. W., & Ashton, J. C. (2012). Spinal cannabinoid CB2 receptors as a target for neuropathic pain: An investigation using chronic constriction injury. Neuroscience, 203, 180-193. doi: 10.1016/j.neuroscience.2011.12.028 Journal - Research Article

Ashton, J. C., Mockett, B., & Maggo, S. D. S. (2012). Cholesterol lowering through HMG CoA reductase inhibitors (statins) impairs long term potentiation and induces anxiety in guinea pigs. Proceedings of the Australian Neuroscience Society (ANS) Annual Scientific Meeting. (pp. 78). Retrieved from http://www.ans.org.au/ans-annual-conference/ Conference Contribution - Published proceedings: Abstract

Brownjohn, P. W., & Ashton, J. C. (2012). A technical note for improving animal welfare and model validity in the chronic constriction injury model of neuropathic pain. European Journal of Pain, 16(10), 1477. doi: 10.1002/j.1532-2149.2012.00199.x Journal - Research Other

Maggo, S., Clark, D., & Ashton, J. C. (2012). The effect of statins on performance in the Morris water maze in guinea pig. European Journal of Pharmacology, 674(2-3), 287-293. doi: 10.1016/j.ejphar.2011.11.006 Journal - Research Article

Breen, C., Brownjohn, P. W., & Ashton, J. C. (2012). The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain. Neuroscience Letters, 508(2), 119-122. doi: 10.1016/j.neulet.2011.12.039 Journal - Research Article

Mandhane, S., Nayak, P., Soni, D., Jain, S., Ashton, J. C., & Rajamannar, T. (2012). Induction of glucose intolerance by acute administration of rimonabant. Pharmacology, 89(5-6), 339-347. doi: 10.1159/000337731 Journal - Research Article

Ashton, J. C. (2012). The use of knockout mice to test the specificity of antibodies for cannabinoid receptors. Hippocampus, 22(3), 643-644. doi: 10.1002/hipo.20946 Journal - Research Other

Brownjohn, P. W., Ashton, J. C., & Chase, J. G. (2012). Microglial encapsulation of motor neurons in models of neuropathic pain: A confound in pain assessment? European Journal of Pain, 16(3), 459-460. doi: 10.1002/j.1532-2149.2011.00101.x Journal - Research Other

Ashton, J. C. (2012). Neuropathic pain: An evolutionary hypothesis. Medical Hypotheses, 78(5), 641-643. doi: 10.1016/j.mehy.2012.01.044 Journal - Research Article

Rivers, J. R., Maggo, S. D. S., & Ashton, J. C. (2012). Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemia. NeuroReport, 23(3), 134-138. doi: 10.1097/WNR.0b013e32834ee47c Journal - Research Article

Ashton, J. C. (2012). Synthetic cannabinoids as drugs of abuse. Current Drug Abuse Reviews, 5(2), 158-168. doi: 10.2174/1874473711205020158 Journal - Research Article

Ashton, J. C. (2012). The atypical cannabinoid O-1602: Targets, actions, and the central nervous system. Central Nervous System Agents in Medicinal Chemistry, 12(3), 233-239. Journal - Research Article

Maggo, S. D. S., Mockett, B. G., & Ashton, J. C. (2012). The effects of chronic statin administration: Assessment of hippocampal spatial memory and long term potentiation in area CA1. Proceedings of the Medical Sciences Congress (MedSci). (pp. 24-25). Retrieved from http://www.medscinz.co.nz/QRW2012%20MedSci%20Abstracts.pdf Conference Contribution - Published proceedings: Abstract

Ashton, J. C. (2015). Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Research, 75, 2400. doi: 10.1158/0008-5472.can-14-3763 Journal - Research Other